Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rabjuvén
- Development stage
- Unknown
- Lead developer
- Wulf Rabe's Biologische Mittel
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Intradermal, Intramuscular, Oral, Subcutaneous, Topical
01
Overview
Rabjuvén is an over-the-counter homeopathic preparation developed by Wulf Rabe's Biologische Mittel (now part of Sanorell Pharma). Originally introduced in 1939 as a mistletoe-based preparation, it is used in naturopathic medicine to support blood and tissue regeneration, particularly as an adjuvant in tumor therapy and for disorders of cell metabolism. The formulation is available in various dosage forms, including ampoules for injection, tablets, and ointments. Its active ingredients include homeopathically potentiated dilutions of *Viscum album* (mistletoe), *Chelidonium majus*, *Strychnos nux-vomica*, and various minerals.
- Brand names
- RabjuvenRabjuvén
- Other names
- Rabjuvén G SalbeRabjuvén WR Kur
Beyond the preview
Go deeper on Rabjuvén.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rabjuvén.